Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Julphar
Fuji
Medtronic
Chinese Patent Office

Generated: August 25, 2019

DrugPatentWatch Database Preview

Claims for Patent: 8,709,081

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,709,081
Title:Cellular scaffold
Abstract: A cellular scaffold that is suitable for tissue regeneration, cell culture and in vitro assays. The invention relates to a layered cell scaffold that is seeded with mesenchymal and ectodermal cells. The layered cellular scaffold comprises an inoculum of mesenchymal cells and ectodermal cells positioned between two opposing scaffolds in a sandwich configuration. The layered cell scaffold provides a functional skin equivalent that is suitable for transplantation and in vitro cell-based assays.
Inventor(s): Kharazi; Alexander (San Diego, CA), Kharazi; Ludmilla (San Diego, CA), Tankovich; Nikolai (San Diego, CA)
Assignee: Stemedica Cell Technologies, Inc. (San Diego, CA)
Application Number:13/251,259
Patent Claims:1. A cellular scaffold arrangement comprising: a first collagen cell scaffold having a first surface and a second surface wherein said second surface of said first cell scaffold is seeded with mesenchymal a second collagen cell scaffold having a first surface and a second surface wherein said first surface of said second cell scaffold is seeded with ectodermal cells; and a composition comprising cell .sup.-factors in contact with at least one of said first collagen cell scaffold, said second collagen cell scaffold, said mesenchymal cells and said ectodermal cells; wherein said second surface of said first scaffold is in contact with said first surface of said second scaffold; wherein said second cell scaffold has the consistency of a sponge.

2. The cellular scaffold of claim 1, wherein said first cell scaffold has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

3. The cellular scaffold of claim 1, wherein at least one of said ectodermal cells and said mesenchymal cells are grown under low oxygen conditions.

4. The cellular scaffold of claim 1, wherein said cell factors are obtained from cells grown under low oxygen conditions.

5. The cellular scaffold of claim 1, wherein said factors are obtained from mesenchymal cells grown under low oxygen conditions.

6. The cellular scaffold of claim 5, wherein said mesenchymal cells grown under low oxygen conditions are bone marrow mesenchymal cells.

7. The cellular scaffold of claim 1, wherein said mesenchymal cells comprise fibroblasts.

8. The cellular scaffold of claim 1, wherein said ectodermal cells comprise precursor keratinocytes.

9. The cellular scaffold of claim 8, wherein said precursor keratinocytes are inhibited in collagenase production.

10. The cellular scaffold of claim 1, wherein said ectodermal cells are derived from basal keratinocytes.

11. A cellular scaffold arrangement comprising: a first collagen cell scaffold having a first surface and a second surface wherein said second surface of said first cell scaffold is seeded with mesenchymal cells; a second collagen cell scaffold having a first surface and a second surface wherein said first surface of said second cell scaffold is seeded with ectodermal cells; and neural stem cells in contact with at least one of said first collagen cell scaffold, said second collagen cell scaffold, said mesenchymal cells and said ectodermal cells; wherein said second surface of said first scaffold is in contact with said first surface of said second scaffold; wherein said second cell scaffold has the consistency of a sponge.

12. The cellular scaffold of claim 11, wherein said first cell scaffold has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

13. The cellular scaffold of claim 11, wherein at least one of said ectodermal cells and said mesenchymal cells are grown under low oxygen conditions.

14. The cellular scaffold of claim 11, wherein said neural stem cells are grown under low oxygen conditions.

15. The cellular scaffold of claim 11, further comprising cell factors in contact with at least one of said first collagen cell scaffold, said second collagen cell scaffold, said mesenchymal cells, said neural stem cells, and said ectodermal cells.

16. The cellular scaffold of claim 15, wherein said cell factors are obtained from bone marrow mesenchymal cells grown under low oxygen conditions.

17. The cellular scaffold of claim 11, wherein said mesenchymal cells comprise fibroblasts.

18. The cellular scaffold of claim 11, wherein said ectodermal cells comprise precursor keratinocytes.

19. The cellular scaffold of claim 18, wherein said precursor keratinocytes are inhibited in collagenase production.

20. The cellular scaffold of claim 11, wherein said ectodermal cells are derived from basal keratinocytes.

Details for Patent 8,709,081

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Stemedica Cell Technologies, Inc. (San Diego, CA) 2026-12-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Federal Trade Commission
Medtronic
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.